NUVA

NuVasive, Inc.

NUVA

Market cap $2.08B

Overview Fund Trends Analyst Outlook Journalist POV

Delisted

NUVA was delisted on the 31st of August, 2023.

Back to rankings

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 0%

Negative

Globus Medical: NuVasive Merger Unlocks Incremental NOPAT Growth

Globus Medical faced market backlash post-merger with NuVasive, but Q1 FY 2024 showed strong growth and integration efforts. Management revised net sales guidance for FY 2024, aiming for high growth and increased profits with lower operating costs. Valuation scenarios suggest potential for risk capital unlock, and a buy rating is supported on fundamentals and cash flow estimates.

See News Rankings